title: Reply to Marchiò et al.: Antitumor immune regulation by angiostatic therapy.
authors.affiliation: Angiogenesis Laboratory, Department of Medical Oncology, Vrije Universiteit Medical Center, 1081 HZ Amsterdam, The Netherlands.
authors.forename: Madelon Q
authors.identifier: 0000-0002-2592-298X
authors.initials: MQ
authors.lastname: Wentink
authors.affiliation: Angiogenesis Laboratory, Department of Medical Oncology, Vrije Universiteit Medical Center, 1081 HZ Amsterdam, The Netherlands.
authors.forename: Elisabeth J M
authors.initials: EJM
authors.lastname: Huijbers
authors.affiliation: Van't Hoff Institute of Molecular Sciences, University of Amsterdam, 1098 HX Amsterdam, The Netherlands; p.timmerman@pepscan.com aw.griffioen@vumc.nl.|Pepscan Therapeutics BV, 8243 RC Lelystad, The Netherlands.
authors.forename: Peter
authors.initials: P
authors.lastname: Timmerman
authors.affiliation: Angiogenesis Laboratory, Department of Medical Oncology, Vrije Universiteit Medical Center, 1081 HZ Amsterdam, The Netherlands; p.timmerman@pepscan.com aw.griffioen@vumc.nl.
authors.forename: Arjan W
authors.initials: AW
authors.lastname: Griffioen
mesh_terms: D020533:Angiogenesis Inhibitors; D006801:Humans; D009389:Neovascularization, Pathologic
chemical_list: D020533:Angiogenesis Inhibitors